|
AADI
|
Aadi Biosciences, Inc.
|
US
|
NASDAQ
|
|
BDX
|
Becton, Dickinson and Company
|
US
|
NYSE
|
|
BIOR
|
Biora Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DRRX
|
DURECT Corporation
|
US
|
NASDAQ
|
|
HRTX
|
Heron Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HTGC
|
Hercules Technology Growth Capital, Inc.
|
US
|
NYSE
|
|
LCTX
|
Lineage Cell Therapeutics, Inc.
|
US
|
AMEX
|
|
LEXX
|
Lexaria Bioscience Corp.
|
US
|
NASDAQ
|
|
MDT
|
Medtronic Inc.
|
US
|
NYSE
|
|
MMM
|
3M Company
|
US
|
NYSE
|
|
NXGL
|
NexGel, Inc
|
US
|
NASDAQ
|
|
PCRX
|
Pacira Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
SRDX
|
SurModics, Inc.
|
US
|
NASDAQ
|
|
STVN
|
Stevanato Group S.p.A
|
US
|
NYSE
|
|
TTNP
|
Titan Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
VRPX
|
Virpax Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
WST
|
West Pharmaceutical Services, Inc.
|
US
|
NYSE
|
|
AVE
|
Avecho Biotechnology Limited
|
AU
|
ASX
|
|
BOT
|
Botanix Pharmaceuticals Ltd
|
AU
|
ASX
|
|
MYX
|
Mayne Pharma Group Ltd
|
AU
|
ASX
|